Found: 14
Select item for more details and to access through your institution.
Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.
- Published in:
- European Journal of Immunology, 2018, v. 48, n. 7, p. 1211, doi. 10.1002/eji.201847498
- By:
- Publication type:
- Article
CD5 Controls Gut Immunity by Shaping the Cytokine Profile of Intestinal T Cells.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.906499
- By:
- Publication type:
- Article
Exploring the induction of preproinsulin-specific Foxp3<sup>+</sup> CD4<sup>+</sup> Treg cells that inhibit CD8<sup>+</sup> T cell-mediated autoimmune diabetes by DNA vaccination.
- Published in:
- Scientific Reports, 2016, p. 29419, doi. 10.1038/srep29419
- By:
- Publication type:
- Article
A Missing PD-L1/PD-1 Coinhibition Regulates Diabetes Induction by Preproinsulin-Specific CD8 T-Cells in an Epitope-Specific Manner.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071746
- By:
- Publication type:
- Article
Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038364
- By:
- Publication type:
- Article
Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 250, doi. 10.3390/cancers16020250
- By:
- Publication type:
- Article
β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17891, doi. 10.1002/cam4.6424
- By:
- Publication type:
- Article
ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53917-5
- By:
- Publication type:
- Article
Ipilimumab in a real‐world population: A prospective Phase IV trial with long‐term follow‐up.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 1, p. 100, doi. 10.1002/ijc.33768
- By:
- Publication type:
- Article
Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155242
- By:
- Publication type:
- Article
Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy.
- Published in:
- Journal of Pathology: Clinical Research, 2019, v. 5, n. 1, p. 53, doi. 10.1002/cjp2.116
- By:
- Publication type:
- Article
Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210399
- By:
- Publication type:
- Article
Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Deficiency in B7-H1 (PD-L1)/PD-1 Coinhibition Triggers Pancreatic β-Cell Destruction by Insulin-Specific, Murine CD8 T-Cells.
- Published in:
- Diabetes, 2010, v. 59, n. 8, p. 1966, doi. 10.2337/db09-1135
- By:
- Publication type:
- Article